The consequences of not having eosinophils.

Gleich, G J; Klion, A D; Lee, J J; Weller, P F

Gleich, G J; Klion, A D; Lee, J J; Weller, P F.

Affiliation

Gleich GJ; University of Utah Health Sciences Center, Salt Lake City, UT 84132-2409, USA. gerald.gleich@hsc.utah.edu

Allergy ; 68(7): 829-35, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23742015

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Eosinophils/immunology; Immunologic Deficiency Syndromes/blood; Immunologic Deficiency Syndromes/immunology; Thymoma/immunology; Thymus Neoplasms/immunology; Animals; Antibodies, Monoclonal, Humanized/adverse effects; Cohort Studies; Disease Models, Animal; Eosinophils/metabolism; Female; Humans; Immunologic Deficiency Syndromes/drug therapy; Incidence; Interleukin-5/adverse effects; Interleukin-5/immunology; Interleukin-5/therapeutic use; Leukocyte Count; Male; Mice; Prognosis; Risk Assessment; Thymoma/blood; Thymoma/epidemiology; Thymus Neoplasms/blood; Thymus Neoplasms/epidemiology

Key words

anti-interleukin 5; deficiency; eosinophil; thymoma

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Eosinophils / Antibodies, Monoclonal, Humanized / Immunologic Deficiency Syndromes Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google